Fresenius Medical Care AG (FMCQF) Short-term Investments (2016 - 2026)

Fresenius Medical Care AG's Short-term Investments history runs 11 years deep, the most recent figure standing at $449.8 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 3.07% year-over-year to $449.8 million; the TTM figure through Mar 2026 stood at $449.8 million (up 3.07% YoY), while the FY2025 annual figure was $519.8 million, up 12.14% from the prior year.
• Short-term Investments for Q1 2026 stood at $449.8 million, down from $519.8 million in the prior quarter.
• The five-year high for Short-term Investments was $651.2 million in Q3 2025, with the low at $252.9 million in Q4 2022.
• The 5-year median for Short-term Investments is $436.4 million (2025), against an average of $414.3 million.
• The sharpest annual moves came in 2022 and 2026: Short-term Investments soared 6369.98% in 2022, then gained 3.07% in 2026.
• Fresenius Medical Care AG's Short-term Investments stood at $252.9 million in 2022, then climbed by 3.88% to $262.7 million in 2023, then surged by 76.42% to $463.5 million in 2024, then grew by 12.14% to $519.8 million in 2025, then slipped by 13.46% to $449.8 million in 2026.
• Business Quant data shows FMCQF's Short-term Investments at $449.8 million in Q1 2026, $519.8 million in Q4 2025, and $651.2 million in Q3 2025.